Connect with others who understand.

Sign up Log in
Quick Links
all articles Treatments A-Z Help Center Guidelines Crisis Accessibility
Resources
Emotional Well-Being Living with MS MS Information MS Symptoms MS Treatments News Videos All Resources
About MyMSTeam
What is This Site Terms of Use Privacy policy
Powered By

Multiple Sclerosis in the News

Study: More Than 50% of People With MS Report at Least 5 Vision Issues

People with multiple sclerosis (MS) report more visual complaints that disrupt daily life than pe...
Posted 03/04/2022

Study: More Than 50% of People With MS Report at Least 5 Vision Issues

People with multiple sclerosis (MS) report more visual complaints that disrupt daily life than pe...
Posted 03/04/2022
read more >

Keto Diet May Help Douse MS-Related Inflammation

A ketogenic diet may reduce inflammation in the brains of people living with multiple sclerosis (...
Posted 03/01/2022

Keto Diet May Help Douse MS-Related Inflammation

A ketogenic diet may reduce inflammation in the brains of people living with multiple sclerosis (...
Posted 03/01/2022
read more >

3 Ways Transparency Has Been Life-Changing During My MS Journey

I wrestled with finding a gentle way of approaching this topic and couldn’t for the life of me fi...
Posted 02/25/2022

3 Ways Transparency Has Been Life-Changing During My MS Journey

I wrestled with finding a gentle way of approaching this topic and couldn’t for the life of me fi...
Posted 02/25/2022
read more >

Actress Jamie-Lynn Sigler on Parenting With MS: ‘Being a Mom and Loving Your Kids Is More Than Enough’

Actress Jamie-Lynn Sigler was 20 years old and playing the role of Meadow Soprano on the HBO show...
Posted 02/22/2022

Actress Jamie-Lynn Sigler on Parenting With MS: ‘Being a Mom and Loving Your Kids Is More Than Enough’

Actress Jamie-Lynn Sigler was 20 years old and playing the role of Meadow Soprano on the HBO show...
Posted 02/22/2022
read more >

Moderna Begins Testing Vaccine for Epstein-Barr — the Virus That May Be Behind MS

Biotechnology company Moderna Therapeutics has launched the first phase of a clinical trial to ev...
Posted 02/18/2022

Moderna Begins Testing Vaccine for Epstein-Barr — the Virus That May Be Behind MS

Biotechnology company Moderna Therapeutics has launched the first phase of a clinical trial to ev...
Posted 02/18/2022
read more >

NFL Stars Don Custom Cleats To Help Tackle MS

As part of the NFL's My Cause My Cleats initiative, New England Patriots defensive tackle Christi...
Posted 02/15/2022

NFL Stars Don Custom Cleats To Help Tackle MS

As part of the NFL's My Cause My Cleats initiative, New England Patriots defensive tackle Christi...
Posted 02/15/2022
read more >

Large-Scale Study Finds Disease-Modifying Drugs Lead to Fewer MS Hospitalizations

A recent study found that disease-modifying drugs (DMDs) reduced hospitalization rates for people...
Posted 02/11/2022

Large-Scale Study Finds Disease-Modifying Drugs Lead to Fewer MS Hospitalizations

A recent study found that disease-modifying drugs (DMDs) reduced hospitalization rates for people...
Posted 02/11/2022
read more >

How I Learned To Stop Inviting Pain to My Party — and Gained Resilience in the Process

Living with a chronic condition has a way of making me feel fragile. Many of us feel as though ou...
Posted 02/08/2022

How I Learned To Stop Inviting Pain to My Party — and Gained Resilience in the Process

Living with a chronic condition has a way of making me feel fragile. Many of us feel as though ou...
Posted 02/08/2022
read more >

MS Relapse Rates Drop to Zero Following Stem Cell Transplants — But ‘Risks Are Real,’ Study Says

People with multiple sclerosis (MS) who undergo hematopoietic stem cell transplantation (HSCT) ma...
Posted 02/05/2022

MS Relapse Rates Drop to Zero Following Stem Cell Transplants — But ‘Risks Are Real,’ Study Says

People with multiple sclerosis (MS) who undergo hematopoietic stem cell transplantation (HSCT) ma...
Posted 02/05/2022
read more >

FDA Approves Easier-To-Swallow Version of Baclofen for Treating Spasticity in MS

A new formulation of the drug baclofen, called Lyvispah, has been approved to treat spasticity in...
Posted 02/04/2022

FDA Approves Easier-To-Swallow Version of Baclofen for Treating Spasticity in MS

A new formulation of the drug baclofen, called Lyvispah, has been approved to treat spasticity in...
Posted 02/04/2022
read more >
MS News

Become a Subscriber

Get the latest news about multiple sclerosis sent to your inbox.

Not now, thanks
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy policy

Thank you for subscribing!

Become a member to get even more: